“Access to understanding should never depend on privilege.”
Kai Pollard, Founder & CEO
Meet Kai
For fifteen years, Kai Pollard helped advance cancer care from the inside. She worked in oncology clinical research, surrounded by oncologists, scientists, and data that shaped how patients were treated every day. Cancer was complex, but it was familiar. It was studied. It was something she helped fight. Then cancer became personal.
When Kai was diagnosed with stage III breast cancer, the ground shifted beneath her. Suddenly, she was no longer reviewing protocols or outcomes—she was sitting in exam rooms, absorbing words that felt heavy and unreal. Despite more than a decade of professional experience in oncology, she struggled to fully understand her own options. Fear, urgency, and the physical toll of treatment made even familiar concepts difficult to grasp.
Cancer does that. It steals clarity when you need it most.
Kai was lucky. Her colleagues rallied around her, offering support that few patients ever receive. Specialists were available at any time. Questions were answered with patience and care. Together, they navigated impossible choices, including the painful decision to end treatment early due to severe side effects.
And that’s when the truth became impossible to ignore.
If she—with fifteen years of oncology expertise—felt overwhelmed, confused, and scared… how could we expect the typical patient to manage?
Most patients don’t have medical training. They don’t have direct access to a dozen experts. Yet they are asked to make life-altering decisions in a healthcare system that is complex, rushed, and often unforgiving. They are expected to advocate for themselves while exhausted, frightened, and sometimes cognitively impaired from treatment.
In oncology, these decisions can mean survival—or loss.
That realization changed Kai forever.
In 2019, she began dedicating her life to supporting cancer patients through the most vulnerable moments of their journey. As someone with a hereditary predisposition to cancer, whose own treatment was guided by tumor genetics, Kai knew the future of cancer care was deeply tied to genomics. In 2020, she pursued a Master’s degree in Individualized Genomics and Health, focusing on equity in precision medicine—because access to understanding should never depend on privilege.
Cancer is not one-size-fits-all. It is written in our genes, our cells, and our stories. The science evolves rapidly, with new precision medicine options emerging constantly—through both clinical care and trials. Providers do their best to apply this knowledge at scale, often choosing treatments that work for most patients.
But no one is “most” patients.
Each person faces cancer with a body that is uniquely theirs, barriers that are uniquely heavy, and a life that will be forever changed by this diagnosis. Kai believes every patient deserves to understand why a recommendation is made, what science stands behind it, and what other paths may exist. More than anything, they deserve to feel seen, heard, and supported when asking hard questions.